HomeTagsIll Hospitalized COVID-19 Patients

Ill Hospitalized COVID-19 Patients

Biotechnology

RedHill Biopharma’s Oral Opaganib Significantly Improves Viral Clearance in Phase 2/3 Study in Severely Ill Hospitalized COVID-19 Patients

PR Newswire - January 14, 2022

RedHill Biopharma Ltd.("RedHill" or the "Company"), a specialty biopharmaceutical company, announced new data from a prespecified analysis of all oral opaganib's Phase 2/3 study...

Hot Topics

Keelvar & DAT Integration Boosts Freight Procurement

Exide Technologies Launches Lithium-Ion Battery for Material Handling

Oglethorpe Power Names Annalisa Bloodworth CEO